Methods and Clinical Issues in Bone Densitometry

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 1883-1894

  Blake, Glen M ^a   Fogelman, Ignac ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882504551     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00021-5     Document Type: Chapter

References (80)

1. R.J. Barr, A. Adebajo, W.D. Fraser, et al. (2005) Can peripheral DXA measurements be used to predict fractures in elderly women living in the community? Osteoporosis Int. 16 1177-1183.
2. D.C. Bauer, C-C. Gluer, J.A. Cauley, et al. (1997) Broadband ultrasonic attenuation predicts fractures strongly and independently of densitometry in older women. Arch. Intern. Med. 157 629-634.
3. D.C. Bauer, L. Palermo, D.M. Black, T.A. Hillier and J.A. Cauley (2001) A prospective study of dry calcaneal quantitative ultrasound and fracture risk in older women: the Study of Osteoporotic Fractures. J. Bone Miner. Res. 16(Suppl 1), S166.
4. D.M. Black, S.R. Cummings, D.B. Karpf, et al. (1996) Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348 1535-1541.
5. D.M. Black, L. Palermo and D. Bauer (2000) How well does bone mass predict long-term risk of hip fracture? Osteoporosis Int. 11(Suppl 2), S59.
6. D.M. Black, S. Boonen, J. Cauley, et al. (2006) Effect of once-yearly infusion of zolendronic acid 5mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: the HORIZON pivotal fracture trial. J. Bone Miner. Res. 21(Suppl 1), S16.
7. G.M. Blake, R.J.M. Herd and I. Fogelman (1996) A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporosis Int. 16 462-470.
8. G.M. Blake and I. Fogelman (2001) Peripheral or central densitometry: does it matter which technique we use? J. Clin. Densitom. 4 83-96.
9. G.M. Blake and I. Fogelman (2002) Clinical use of instruments that measure peripheral bone mass. Curr Opin Endocrinol Diabetes 9 502-511.
10. G.M. Blake, R. Patel, K.M. Knapp and I. Fogelman (2003) Does the combination of two BMD measurements improve fracture discrimination? J. Bone Miner. Res. 18 1955-1963.
11. G.M. Blake, D.J. Chinn, S.A. Steel, et al. (2005) A list of device specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporosis Int. 16 2149-2156.
12. F. Borgstrom, O. Johnell, J.A. Kanis, et al. (2006) At what hip fracture risk is it cost effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporosis Int. 17 1459-1471.
13. F. Borgstrom, A. Carisson, H. Sintonen, et al. (2006) Cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective. Osteoporosis Int. 17 996-1007.
14. F. Borgstrom, B. Jonsson, O. Strom and J.A. Kanis (2006) An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting based on the results of the SOTI and TROPOS trials. Osteoporosis Int. 17 1781-1793.
15. J.R. Centre, T.V. Nguyen, D. Schneider, P.N. Sambrook and J.A. Eisman (1999) Mortality after all major types of osteoporotic fractures in men and women: an observational study. Lancet 353 878-882.
16. C.H. Chesnut, A. Skag, C. Christiansen, et al. (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J. Bone Miner. Res. 19 1241-1249.
17. C. Cooper, E.J. Atkinson, S.J. Jacobsen, M. O'Fallon and L.J. Melton (1993) Population based study of survival after osteoporotic fractures. Am. J. Epidemiol. 137 1001-1005.
18. S.R. Cummings, D.M. Black, M.C. Nevitt, et al. (1993) Bone density at various sites for prediction of hip fractures. Lancet 341 72-75.
19. S.R. Cummings, D.M. Black, D.E. Thompson, et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280 2077-2082.
20. S.R. Cummings and L.J. Melton (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359 1761-1767.
21. C. De Laet, A. Oden, H. Johansson, O. Johnell, B. Jonsson and J.A. Kanis (2005) The impact of the use of multiple risk factors for fracture on case-finding strategies: a mathematical approach. Osteoporosis Int. 16 313-318.
22. C. De Laet, J.A. Kanis, A. Oden, et al. (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporosis Int. 16 1330-1338.
23. C. Durosier, D. Hans, M-A. Kreig and A-M. Schott (2006) Prediction and discrimination of osteoporotic hip fracture in postmenopausal women. J. Clin. Densitom. 9 475-495.
24. R. Eastell (1998) Treatment of postmenopausal osteoporosis. N. Engl. J. Med. 338 736-746.
25. B. Ettinger, D.M. Black, B.H. Mitlak, et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. JAMA 282 637-645.
26. K.G. Faulkner, L.A. Roberts and M.R. McClung (1996) Discrepancies in normative data between Lunar and Hologic DXA systems. Osteoporosis Int. 6 432-436.
27. K.G. Faulkner (1998) Bone densitometry: choosing the proper site to measure. J. Clin. Densitom. 1 279-285.
28. K.G. Faulkner, E. Von Stetton and P. Miller (1999) Discordance in patient classification using T-scores. J. Clin. Densitom. 2 343-350.
29. I. Fogeman and G.M. Blake (2000) Different approaches to bone densitometry. J. Nucl. Med. 41 2015-2025.
30. H.K. Genant, K. Engelke, T. Fuerst, et al. (1996) Noninvasive assessment of bone mineral and structure: state of the art. J. Bone Miner. Res. 11 707-730.
31. H.K. Genant, C. Cooper, G. Poor, et al. (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporosis Int. 10 259-264.
32. C-C. Gluer (1999) Monitoring skeletal change by radiological techniques. J. Bone Miner. Res. 14 1952-1962.
33. S.L. Greenspan, H.G. Bone, M.P. Ettinger, et al. (2007) Effect of recombinant human parathyroid hormone (1–84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis. Ann. Intern. Med. 146 326-339.
34. G. Guglielmi and T.F. Lang (2002) Quantitative computed tomography. Semin. Musculoskelet. Radiol. 6 219-227.
35. D. Hans, P. Dargent-Molina, A.M. Schott, et al. (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348 511-514.
36. D. Hans, A-M. Schott, F. Duboeuf, C. Durosier and P.J. Meunier (2004) Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study. Bone 35 357-363.
37. J. Hanson (1997) Standardization of femur BMD. J. Bone Miner. Res. 12 1316-1317.
38. S.T. Harris, N.B. Watts, H.K. Genant, et al. (1999) Effects of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. JAMA 282 1344-1352.
39. International Society for Clinical Densitometry (ISCD) (2005). Official positions of the International Society for Clinical Densitometry: updated 2005. Available online at: www.iscd.org/visitors/positions/official.cfm.
40. H. Johansson, A. Oden, O. Johnell, et al. (2004) Optimisation of BMD measurements to identify high risk groups for treatment–a test analysis. J. Bone Miner. Res. 19 906-913.
41. O. Johnell, J.A. Kanis, A. Oden, et al. (2005) Predictive value of BMD for hip and other fractures. J. Bone Miner. Res. 20 1185-1194.
42. J.A. Kanis, P. Delmas, P. Burckhardt, C. Cooper and D. Torgerson (1997) Guidelines for diagnosis and treatment of osteoporosis. Osteoporosis Int. 7 390-406.
43. J.A. Kanis and C-C. Gluer (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int. 11 192-202.
44. J.A. Kanis, O. Johnell, A. Oden, A. Dawson, C. De Laet and B. Jonsson (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis Int. 12 989-995.
45. J.A. Kanis, A. Oden, O. Johnell, B. Jonsson, C. De Laet and A. Dawson (2001) The burden of osteoporotic fractures: a method of setting intervention thresholds. Osteoporosis Int. 12 417-427.
46. J.A. Kanis (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 1929-1936.
47. J.A. Kanis, D. Black, C. Cooper, et al. (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis Int. 13 527-536.
48. J.A. Kanis, O. Johnell, C. De Laet, et al. (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35 375-382.
49. J.A. Kanis, H. Johansson, A. Oden, et al. (2004) A meta-analysis of prior corticosteroid use and fracture risk. J. Bone Miner. Res. 19 893-899.
50. J.A. Kanis, H. Johansson, A. Oden, et al. (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35 1029-1037.
51. J.A. Kanis, F. Borgstrom, C. De Laet, et al. (2005) Assessment of fracture risk. Osteoporosis Int. 16 581-589.
52. J.A. Kanis, O. Johnell, A. Oden, et al. (2005) Smoking and fracture risk: a meta-analysis. Osteoporosis Int. 16 155-162.
53. J.A. Kanis, H. Johansson, O. Johnell, et al. (2005) Alcohol intake as a risk factor for fracture. Osteoporosis Int. 16 737-742.
54. J.A. Kanis, F. Borgstrom, N. Zethraeus, O. Johnell, A. Oden and B. Jonsson (2005) Intervention thresholds for osteoporosis in the UK. Bone 36 22-32.
55. J.A. Kanis, F. Borgstrom, O. Johnell, A. Oden, D. Sykes and B. Jonsson (2005) Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study. Osteoporosis Int. 16 15-25.
56. J.A. Kanis, O. Johnell, A. Oden, et al. (2006) The use of multiple sites for the diagnosis of osteoporosis. Osteoporosis Int. 17 527-534.
57. K-T. Khaw, J. Reeve, R. Luben, et al. (2004) Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study. Lancet 363 197-202.
58. T.F. Lang, G. Guglielmi, C. Van Kuijk, A. De Serio, M. Cammisa and H.K. Genant (2002) Measurement of vertebral bone mineral density at the spine and proximal femur by volumetric quantitative computed tomograph and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30 247-250.
59. A.C. Looker, H.W. Wahner, W.L. Dunn, et al. (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporosis Int. 8 468-489.
60. Y. Lu, H.K. Genant, J. Shepherd, et al. (2001) Classification of osteoporosis based on bone mineral densities. J. Bone Miner. Res. 16 901-910.
61. D. Marshall, O. Johnell and H. Wedel (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 1254-1259.
62. M.R. McClung, P. Geusens, P.D. Miller, et al. (2001) Effect of risedronate treatment on hip fracture risk in elderly women. N. Engl. J. Med. 344 333-340.
63. L.J. Melton, S.E. Gabriel, C.S. Crowson, A.N.A. Tostesen, O. Johnell and J.A. Kanis (2003) Cost-equivalence of different osteoporotic fractures. Osteoporosis Int. 14 383-388.
64. P.J. Meunier, C. Roux, E. Seeman, et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350 459-468.
65. P.D. Miller, E.S. Siris, E. Barrett-Connor, et al. (2002) Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J. Bone Miner. Res. 17 2222-2230.
66. R.M. Neer, C.D. Arnaud, J.R. Zanchetta, et al. (2001) Effect of recombinant human parathyroid hormone (1–34) fragment on spine and non-spine fractures and bone mineral density in postmenopausal osteoporosis. N. Engl. J. Med. 344 1434-1441.
67. NOF (1998) Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporosis Int. 8(Suppl 4), S7-s80.
68. E.S. Orwoll, L.M. Marshall, B.K. Chan, et al. (2006) Measures of hip structure are important determinants of hip fracture risk independent of BMD. J. Bone Miner. Res. 20(Suppl 1), S35.
69. R. Patel, G.M. Blake, J. Rymer and I. Fogelman (2000) Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporosis Int. 11 68-75.
70. S.M.F. Pluijm, W.C. Graafmans, L.M. Bouter and P. Lips (1999) Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporosis Int. 9 550-556.
71. N.F. Ray, J.K. Chan, M. Thamer and L.J. Melton (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J. Bone Miner. Res. 12 24-35.
72. J.Y. Reginster, E. Seeman, M.C. De Vernejoul, et al. (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: TROPOS study. J. Clin. Endocrinol. Metab. 90 2816-2822.
73. E. Seeman, B. Vellas, C. Benhamou, et al. (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J. Bone Miner. Res. 21 1113-1120.
74. A. Stewart and D.M. Reid (2002) Quantitative ultrasound in osteoporosis. Semin. Musculoskelet. Radiol. 6 229-232.
75. K.L. Stone, D.G. Seeley, L-Y. Lui, et al. (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J. Bone Miner. Res. 18 1947-1954.
76. T. Storm, G. Thamsborg, T. Steiniche, H.K. Genant and O.H. Sorensen (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N. Engl. J. Med. 322 1265-1271.
77. Surgeon General's report (2004). Bone health and osteoporosis: a report of the Surgeon General. Available online at: www.surgeongeneral.gov/library/bonehealth.
78. World Health Organisation (WHO) (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: technical report series 843. Geneva: WHO
79. A. Woodhouse and D.M. Black (2000) BMD at various sites for the prediction of hip fracture: a meta-analysis. J. Bone Miner. Res. 15(Suppl 2), S145.
80. N. Zethraeus, F. Borgstrom, O. Strom and J.A. Kanis (2007) Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporosis Int. 18 9-23.